Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Lebanon, PA MSA — September 2026

Lebanon's tight labor market meets a statewide life sci hiring surge.

Lebanon MSA unemployment near 3.6% against Pennsylvania's 4.1%, as statewide life sciences job postings tripled year-over-year — a combination pressuring Lebanon employers to defend scarce regulatory and manufacturing talent against Philadelphia-area recruiting.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • Lebanon MSA unemployment: 3.6% — June 2026, down from 3.7% a year earlier
  • PA life sci job postings growth: ~3x YoY — August 2026 vs August 2025, statewide
  • Lebanon County manufacturing wage: $66,329/yr — vs $52,955 metro-wide median salary
  • PA statewide unemployment: 4.1%–4.2% — 12-mo avg vs Lebanon's 3.6% June reading

Key takeaways

Manufacturing wage floor is higher here than it looks.

County manufacturing pay averages $66,329 against a metro median of $52,955, meaning life sci employers hiring technicians and operators compete against an already-elevated local wage base rather than a low-cost labor pool. Build-vs-outsource math for Lebanon-based manufacturing should assume compensation parity with regional peers, not a cost advantage.

Statewide hiring surge hasn't reached labor supply yet.

Pennsylvania life sciences postings tripled year-over-year while statewide unemployment drifted to 4.2%, suggesting demand is outpacing available specialized talent rather than reflecting broad-based job growth. Expect longer time-to-fill for regulatory and quality roles sourced locally in Lebanon rather than from the Philadelphia talent cluster.

Outsourcing economics are shifting in Pennsylvania's favor.

Minaris' AAV manufacturing partnership with Asimov and continued Philadelphia CDMO specialization signal that cell and gene therapy capacity once requiring captive build-out is increasingly available in-state. Smaller Lebanon-area biotech and device firms evaluating internal manufacturing expansion may find in-state CDMO capacity now closes gaps that previously forced costly out-of-state partnerships.

Worker leverage is softening even as roles stay open.

Reduced quit rates and weakening wage negotiating power statewide coexist with 64% of biopharma organizations still actively recruiting nationally, a split that rewards employers who hold steady on comp for critical roles while others may see softer counteroffer pressure. Current conditions suggest selective retention spend on regulatory and CMC talent rather than across-the-board increases.

Median advertised pay by role — Lebanon, PA MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$89,211$124,624$141,205Significant increase$131,354
Clinical Research Associate *$61,167$80,883$100,914Significant increase$90,956
Lab Technician *$39,619$46,681$52,287Moderate decline$47,402
Regulatory Affairs Specialist *$66,798$95,346$112,818Stable$104,000
Clinical Data Manager *$97,693$142,800$164,232Moderate increase$123,031
Biostatistician *$107,580$139,109$159,860Moderate increase$133,322
Validation Engineer *$89,151$106,202$113,415Stable$108,377

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Lebanon MSA unemployment held near 3.6% through mid-2026, among the tightest 40 metro labor markets nationally with under 100,000 workers in the labor force, while manufacturing — 17.8% of county employment at an average $66,329 — continues to anchor wage floors above the metro's $52,955 median. Statewide life sciences hiring tripled year-over-year in postings even as Pennsylvania's broader unemployment rate crept to 4.1%, a combination that signals employers are competing hard for specialized talent even as general labor supply loosens slightly.

What it means

Lebanon sits outside Philadelphia's dense 1,200-company life sciences cluster, meaning local employers compete for regulatory, quality, and manufacturing talent against better-funded Philadelphia-area recruiters offering GSK- and Insmed-scale openings without offering a comparable local talent pool to draw from. Tight regional unemployment combined with statewide softening in worker negotiating leverage (12-month average 4.2%, reduced quit rates) creates a narrow window where retention investments in scarce CMC and regulatory talent may cost less than they will in twelve months if Philadelphia-area hiring accelerates further. Consider reviewing retention premiums for quality and regulatory affairs staff against Philadelphia-metro advertised rates before those differentials widen.

Looking ahead

Worth watching: Philadelphia-area hiring announcements from GSK (40+ roles) and Insmed (60+ roles) may pull regulatory and manufacturing talent out of the broader Pennsylvania labor pool, including Lebanon-area commuters. Track whether Lebanon-based employers see increased attrition toward Philadelphia-metro openings over the next two pay cycles.

Emerging pressure point: Pennsylvania has logged 174 WARN filings over 24 months affecting 27,932 workers, concentrated outside life sciences but including logistics and manufacturing firms geographically close to Lebanon. Watch whether displaced manufacturing or logistics workers begin appearing in applicant pools for life sci production and quality roles.

Potential inflection point: September's national biopharma layoffs (BioMarin, Bristol Myers) concentrated in consolidation functions rather than execution roles; monitor whether released mid-career regulatory or quality talent becomes available regionally as companies restructure rather than cut floor-level hiring.

Expected: BLS has not yet released September 2026 metro-level unemployment data for Lebanon; the June reading of 3.6% remains the most current benchmark. Expect a data gap in near-term reporting that limits visibility into whether the tightening trend held through Q3.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.